AI, machine learning to help Indian pharma industry to pivot on innovation

New Delhi, Dec 26 As technological advancements like AI, machine learning and precision medicine revolutionise drug discovery, manufacturing and patient care, Indian pharmaceutical industry is set for a 'profound transformation' in 2025 with innovation, wider global access and improvement in quality becoming key themes for the future. The industry, which is expected to grow nearly two-fold to around USD 130 billion in size by 2030, is looking to take advantage of conducive policies, demographic and digital talent, in making India play a pivotal role in advancing global health for all. Initiatives in terms of quality, innovation and wider global reach will help the Indian pharma sector to realise the potential," according to Indian Pharmaceutical Alliance Secretary General Sudarshan Jain. Matai noted that the notification of the Patent Rules 2024, waivers for Phase 3 clinical trials for certain categories of drugs already approved in well-regulated markets, and the much-awaited Trade and Economic Partnership Agreement with European Free Trade Association states reflect India's progressive strides toward creating a dynamic, globally competitive pharmaceutical sector that is driven by innovation.